Stockscreener 앱 받기
80.70
2.02%
1.60
시간 외 거래:
81.30
0.60
+0.74%
전일 마감가:
$79.10
열려 있는:
$79.415
하루 거래량:
3.89M
Relative Volume:
1.26
시가총액:
$10.51B
수익:
$638.78M
순이익/손실:
$-22.66M
주가수익비율:
-462.73
EPS:
-0.1744
순현금흐름:
$122.18M
1주 성능:
+8.48%
1개월 성능:
+23.93%
6개월 성능:
+338.83%
1년 성능:
+518.87%
1일 변동 폭
$77.50
$82.68
1주일 범위
$71.44
$82.68
52주 변동 폭
$11.16
$82.68
10X 제노믹스 Stock (TXG) Company Profile
명칭
10 X Genomics Inc
전화
(925) 401-7300
주소
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG vs VEEV, TEM, BTSG, HNGE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
80.70 | 8.94B | 638.78M | -22.66M | 122.18M | -0.1744 |
VEEV
Veeva Systems Inc
|
260.91 | 42.48B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
77.19 | 10.71B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
56.55 | 11.62B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
94.15 | 7.15B | 646.34M | -512.40M | 202.76M | -6.6871 |
10X 제노믹스 Stock (TXG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-31 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-12-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-11 | 개시 | Piper Sandler | Neutral |
| 2025-02-13 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | 개시 | Leerink Partners | Outperform |
| 2024-07-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-07-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-10 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-06-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-05-01 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-10 | 개시 | Barclays | Overweight |
| 2023-03-31 | 개시 | Stephens | Overweight |
| 2023-02-02 | 개시 | UBS | Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-08-18 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-07-25 | 개시 | Canaccord Genuity | Buy |
| 2022-07-15 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-15 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-09-14 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-03-15 | 개시 | William Blair | Outperform |
| 2020-12-02 | 개시 | Goldman | Neutral |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-07-10 | 개시 | Stifel | Buy |
| 2020-03-05 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-10-07 | 개시 | BofA/Merrill | Buy |
| 2019-10-07 | 개시 | Cowen | Outperform |
| 2019-10-07 | 개시 | JP Morgan | Overweight |
| 2019-09-24 | 개시 | Evercore ISI | Outperform |
모두보기
10X 제노믹스 주식(TXG)의 최신 뉴스
Korea's Lunit announces collaboration with 10x Genomics for AI-enabled pathology analysis of cancer - BioSpectrum Asia
Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know - Yahoo Finance
10x Genomics (TXG) CFO Adam Taich Sells 46,388 Shares - GuruFocus
10x genomics CFO Adam Taich disposes of $2.99 million in company stock - Investing.com Nigeria
10x Genomics Inc (TXG) Shares Surge 3.3% -- What GF Score of 56 Tells Investors - GuruFocus
10x Genomics (TXG) CFO sells shares under preset trading plan - Stock Titan
10x Genomics CFO Adam Taich sells USD 2.99 million in common shares - Bitget
10x Genomics to Use Lunit’s AI-Powered Pathology Platform for Oncology Biomarker Discovery - GenomeWeb
AI will pair tissue scans with molecular maps in cancer studies - Stock Titan
10x genomics director Stuelpnagel sells $1.2 million in shares By Investing.com - Investing.com Australia
symbol__ Stock Quote Price and Forecast - CNN
10x Genomics (NASDAQ: TXG) executive plans multimillion-dollar stock sale - Stock Titan
10x Genomics Insider John R. Stuelpnagel Sells 20,000 Shares Between $60.66 and $62.61 on September 3, 2026 (NASDAQ: TXG) - kalkinemedia.com
10x Genomics stock hits 52-week high at 66.95 USD By Investing.com - Investing.com South Africa
Macrogen to offer 10x Genomics spatial biology platform in Asia first - Korea Biomedical Review
10x genomics director Stuelpnagel sells $1.2 million in shares - investing.com
10x Genomics Inc (TXG) Stock Up 4.7% but GF Value Says Overvalued -- GF Score: 56/100 - GuruFocus
10x Genomics (TXG) director offloads 20,000 shares in open-market trades - Stock Titan
T. Rowe Price reports 10%+ holding in 10x Genomics (TXG) - Stock Titan
Stifel reiterates Buy rating on 10X Genomics stock - investing.com
10X Genomics Inc (TXG) Key Financial Ratios – Valuation, Profitability & More - Value Research
10x Genomics (TXG) CEO holds 1,075,249 shares after 100-share gift - Stock Titan
Founder trust at 10x Genomics (NASDAQ: TXG) moves to sell 20,000 shares - Stock Titan
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead? - finance.yahoo.com
TXG Stock Price and Chart — NASDAQ:TXG - TradingView
A Look at 10x Genomics Inc (TXG) After 4.0% Decline -- GF Value $18.36 vs Price $60.00 - GuruFocus
RBC Capital initiates 10X Genomics stock with Sector Perform rating - investing.com
10X GENOMICS, INC. : RBC INITIATES COVERAGE WITH SECTOR PERFORM RATING; TARGET PRICE $70 - Bitget
Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit - Benzinga
TXG Stock Down Despite Patent Verdict Win Against Parse Biosciences - TradingView
10X Genomics Inc (TXG) Peer Comparison – Compare with Others - Value Research
10x Genomics Wins Patent Infringement Verdict against Parse Biosciences - marketscreener.com
Delaware jury finds Parse infringed three genetic-sequencing patents - Reuters
TXG - Finviz
10x Genomics Inc (TXG) Shares Fall 5.1% -- GF Value Says Still O - GuruFocus
10x Genomics (TXG) CEO sells 10,486 shares under 10b5-1 plan - Stock Titan
10x Genomics wins jury award in Qiagen patent row (TXG:NASDAQ) - Seeking Alpha
10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences - Porterville Recorder
10x Genomics Inc (TXG) Director Shehnaaz Suliman Sells 2,207 Sha - GuruFocus
10x Genomics (NASDAQ: TXG) CEO sells for taxes, still holds 1,085,835 shares - Stock Titan
10x Genomics (NASDAQ: TXG) CEO lines up another share sale - Stock Titan
10x Genomics (NASDAQ: TXG) exec to sell 16,614 shares - Stock Titan
10x Genomics (NASDAQ: TXG) insider plans sale of 17,948 shares - Stock Titan
10x Genomics (NASDAQ: TXG) holder to sell about $871K in stock - Stock Titan
10x Genomics (TXG) CEO gifts 4,000 shares in stock donation - Stock Titan
10x Genomics: The Turnaround Is Real, But Atera Now Has To Deliver (Rating Upgrade) (TXG) - Seeking Alpha
Fed. Circ. Backs PTAB's Ax Of 10x Genomics Patent Claims - law360.com
Federal Circuit Upholds PTAB Obviousness Rulings Against Single Cell Sequencing Patents - IPWatchdog.com
10x Genomics Gains as Investors Extend Post-Earnings Rally on Atera Demand - Quiver Quantitative
10x Genomics’ Bid to Revive Patents Rejected by Federal Circuit - Bloomberg Law News
10x Genomics (NASDAQ:TXG) Reaches New 52-Week HighWhat's Next? - MarketBeat
10X 제노믹스 (TXG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.24%
0.32%
자본화:
|
볼륨(24시간):